[1] 杜树山,徐艳春,魏璐雪.天南星中脂肪酸的分析[J].北京中医药大学学报,2003(2):44-46. [2] 戚笑笑,李红,杜钢军.天南星抗肿瘤的初步研究[J].河南大学学报(医学版),2014,33(2):85-87. [3] 杨宗辉,尹建元,魏征人,等.天南星提取物诱导人肝癌SMMC-7721细胞凋亡及其机制的实验研究[J].中国老年学杂志,2007(2):142-144. [4] 张志林,汤建华,陈勇,等.中药天南星醇提物抗肿瘤活性的研究[J].陕西中医,2010,31(2):242-243. [5] 张岩,王帅,包永睿,等.天南星提取液抗肺癌细胞活性研究[J].中国当代医药,2013,20(12):80-81,83. [6] HAO D C,XIAO P G.Network pharmacology:A rosetta stone for traditional Chinese medicine[J].Drug Dev Res,2014,75(5):299-312. [7] LECCA P,RE A.Network-oriented approaches to anticancer drug response[J].Methods Mol Biol,2017,1513:101-117. [8] 李冰涛,翟兴英,李佳,等.基于网络药理学葛根解热作用机制研究[J].药学学报,2019,54(8):1409-1416. [9] 刘志华,孙晓波.网络药理学:中医药现代化的新机遇[J].药学学报,2012,47(6):696-703. [10] YUAN H,MA Q,CUI H,et al.How can synergism of traditional medicines benefit from network pharmacology?[J].Molecules,2017,22(7):E1135. [11] TAO W,XU X,WANG X,et al.Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease[J].J Ethnopharmacol,2013,145(1):1-10. [12] XIANG S Y,ZHAO J,LU Y,et al.Network pharmacology-based identification for therapeutic mechanism of Ling-Gui-Zhu-Gan decoction in the metabolic syndrome induced by antipsychotic drugs[J].Comput Biol Med,2019,110:1-7. [13] HUA Y L,MA Q,YUAN ZW,et al.A novel approach based on metabolomics coupled with network pharmacology to explain the effect mechanisms of Danggui Buxue Tang in anaemia[J].Chin J Nat med,2019,17(4):275-290. [14] 罗磊.类固醇受体共激活因子3在人肝癌组织中的表达水平及其临床意义[D].郑州:郑州大学,2014. [15] 杨沙,段灿灿,晏仁义,等.基于网络药理学的半枝莲抗肿瘤活性成分及整合作用机制研究[J].中草药,2018,49(15):3471-3482. [16] 张晓敏,刘静,高世超,等.ADH1B和ALDH2基因多态性与相关疾病研究进展[J].检验医学,2019,34(3):271-275. [17] 王训翠,储明星,陈宏权.前列腺素内过氧化物合酶2基因的研究进展[J].生命科学,2004,16(1):31-34. [18] GUO S J,LI X B,GAO M,et al.Synergistic association of PTGS2 and CYP2E1 genetic polymorphisms with lung cancer risk in northeastern Chinese[J].PLoS One,2012,7(6):e39814. [19] FESTA-VASCONCELLOS J S,PIRANDA D N,AMARAL L M,et al.Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis:association between PTGS2 haplotypes and histopathological features[J].Breast cancer research and treatment,2012,132(1):251-258. [20] 杨帆.NCOA2激活Wnt信号通路导致胃癌发生和转移的机制[D].福州:福建医科大学,2017. [21] LEE S,OH T,CHUNG H,et al.Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.[J].International journal of oncology,2011,40(3):889-898. [22] 潘宇晨,王佳丽,侯亚义.肿瘤坏死因子α在自身免疫性疾病中的研究进展[J].药学进展,2017,41(12):883-889. [23] 黄霓,游金辉.VEGF、p53在恶性肿瘤骨转移中相关机制的研究进展[J].医学综述,2018,24(11):2160-2164. [24] 李斌.生物体液中酪氨酸及其代谢产物的水平与乳腺癌的相关性研究[D].南昌:南昌大学,2018. [25] 施银,冯晓兰,谢李芬,等.PI3K/AKT信号通路在肿瘤中的研究进展[J].生命的化学,2018,38(3):421-426. [26] 王华,李奇奇,朱子清,等.结直肠癌相关信号通路的研究进展[J].生命的化学,2018,38(3):415-420. [27] 严丽,李清怀,冀宏,等.AMPK-ACC信号通路在甲状腺乳头状癌中的表达及意义[J].河北医科大学学报,2016,37(11):1270-1274,1278. [28] 唐海林.钙信号通路在DADS诱导人鼻咽癌CNE2细胞凋亡的机制研究[D].湖南衡阳:南华大学,2007. [29] 樊江浩,刘揆亮,吴静.蛋白多糖在肿瘤血管生成中的作用[J].临床与病理杂志,2016,36(4):515-519. |